Early experience in avoiding biopsies for biopsy-naive men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2: A 2-year follow-up study

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Early experience in avoiding biopsies for biopsy-naive men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2 : A 2-year follow-up study. / Kortenbach, Karen-Cecilie; Logager, Vibeke; Thomsen, Henrik S.; Boesen, Lars.

I: Acta Radiologica Open, Bind 11, Nr. 4, 20584601221094825, 2022.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Kortenbach, K-C, Logager, V, Thomsen, HS & Boesen, L 2022, 'Early experience in avoiding biopsies for biopsy-naive men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2: A 2-year follow-up study', Acta Radiologica Open, bind 11, nr. 4, 20584601221094825. https://doi.org/10.1177/20584601221094825

APA

Kortenbach, K-C., Logager, V., Thomsen, H. S., & Boesen, L. (2022). Early experience in avoiding biopsies for biopsy-naive men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2: A 2-year follow-up study. Acta Radiologica Open, 11(4), [20584601221094825]. https://doi.org/10.1177/20584601221094825

Vancouver

Kortenbach K-C, Logager V, Thomsen HS, Boesen L. Early experience in avoiding biopsies for biopsy-naive men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2: A 2-year follow-up study. Acta Radiologica Open. 2022;11(4). 20584601221094825. https://doi.org/10.1177/20584601221094825

Author

Kortenbach, Karen-Cecilie ; Logager, Vibeke ; Thomsen, Henrik S. ; Boesen, Lars. / Early experience in avoiding biopsies for biopsy-naive men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2 : A 2-year follow-up study. I: Acta Radiologica Open. 2022 ; Bind 11, Nr. 4.

Bibtex

@article{5c232a432ed44c09954e7ce483d03803,
title = "Early experience in avoiding biopsies for biopsy-naive men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2: A 2-year follow-up study",
abstract = "Background: Only limited data have been published on the diagnostic accuracy of combining biparametric (bp) magnetic resonance imaging (MRI) and prostate-specific antigen density (PSAd) to rule out biopsies.Purpose: The purpose is to assess the 2-year risk of being diagnosed with sPCa following the strategy of avoiding immediate biopsies in men with non-suspicious bp MRIs and a PSAdMaterial and Methods: Two hundred biopsy-naive men with clinical suspicion of PCa underwent a pre-biopsy bp MRI from March to July 2019. Of these, 109 men had a Prostate Imaging Reporting and Data System (PI-RADS) score of 1-3 including 77 men with calculated PSAd = 0.15 ng/mL(2) underwent systematic biopsies and targeted biopsies of any PI-RADS 3 lesion.Results: One of the 77 men (1.3%) had an sPCa diagnosed within 2 years of follow-up. All men were referred back to their general practitioner within 1 year and 9% (7/77) were re-referred to the urology department during follow-up. Among these men, 43% (3/7) continued to have PSA levels that were above their individual thresholds at confirmatory testing and underwent secondary MRI scans.Conclusions: No biopsies for men with bpMRI results exhibiting maximum PI-RADS 3 and with a PSAd",
keywords = "Biomarkers, biparametric magnetic resonance imaging, diagnostic imaging, magnetic resonance imaging, outcome assessment, prostate cancer, ISUP CONSENSUS CONFERENCE, INTERNATIONAL-SOCIETY, COMPLICATIONS, ASSOCIATION, DIAGNOSIS, MRI",
author = "Karen-Cecilie Kortenbach and Vibeke Logager and Thomsen, {Henrik S.} and Lars Boesen",
year = "2022",
doi = "10.1177/20584601221094825",
language = "English",
volume = "11",
journal = "Acta Radiologica Short Reports",
issn = "2047-9816",
publisher = "SAGE Publications",
number = "4",

}

RIS

TY - JOUR

T1 - Early experience in avoiding biopsies for biopsy-naive men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2

T2 - A 2-year follow-up study

AU - Kortenbach, Karen-Cecilie

AU - Logager, Vibeke

AU - Thomsen, Henrik S.

AU - Boesen, Lars

PY - 2022

Y1 - 2022

N2 - Background: Only limited data have been published on the diagnostic accuracy of combining biparametric (bp) magnetic resonance imaging (MRI) and prostate-specific antigen density (PSAd) to rule out biopsies.Purpose: The purpose is to assess the 2-year risk of being diagnosed with sPCa following the strategy of avoiding immediate biopsies in men with non-suspicious bp MRIs and a PSAdMaterial and Methods: Two hundred biopsy-naive men with clinical suspicion of PCa underwent a pre-biopsy bp MRI from March to July 2019. Of these, 109 men had a Prostate Imaging Reporting and Data System (PI-RADS) score of 1-3 including 77 men with calculated PSAd = 0.15 ng/mL(2) underwent systematic biopsies and targeted biopsies of any PI-RADS 3 lesion.Results: One of the 77 men (1.3%) had an sPCa diagnosed within 2 years of follow-up. All men were referred back to their general practitioner within 1 year and 9% (7/77) were re-referred to the urology department during follow-up. Among these men, 43% (3/7) continued to have PSA levels that were above their individual thresholds at confirmatory testing and underwent secondary MRI scans.Conclusions: No biopsies for men with bpMRI results exhibiting maximum PI-RADS 3 and with a PSAd

AB - Background: Only limited data have been published on the diagnostic accuracy of combining biparametric (bp) magnetic resonance imaging (MRI) and prostate-specific antigen density (PSAd) to rule out biopsies.Purpose: The purpose is to assess the 2-year risk of being diagnosed with sPCa following the strategy of avoiding immediate biopsies in men with non-suspicious bp MRIs and a PSAdMaterial and Methods: Two hundred biopsy-naive men with clinical suspicion of PCa underwent a pre-biopsy bp MRI from March to July 2019. Of these, 109 men had a Prostate Imaging Reporting and Data System (PI-RADS) score of 1-3 including 77 men with calculated PSAd = 0.15 ng/mL(2) underwent systematic biopsies and targeted biopsies of any PI-RADS 3 lesion.Results: One of the 77 men (1.3%) had an sPCa diagnosed within 2 years of follow-up. All men were referred back to their general practitioner within 1 year and 9% (7/77) were re-referred to the urology department during follow-up. Among these men, 43% (3/7) continued to have PSA levels that were above their individual thresholds at confirmatory testing and underwent secondary MRI scans.Conclusions: No biopsies for men with bpMRI results exhibiting maximum PI-RADS 3 and with a PSAd

KW - Biomarkers

KW - biparametric magnetic resonance imaging

KW - diagnostic imaging

KW - magnetic resonance imaging

KW - outcome assessment

KW - prostate cancer

KW - ISUP CONSENSUS CONFERENCE

KW - INTERNATIONAL-SOCIETY

KW - COMPLICATIONS

KW - ASSOCIATION

KW - DIAGNOSIS

KW - MRI

U2 - 10.1177/20584601221094825

DO - 10.1177/20584601221094825

M3 - Journal article

VL - 11

JO - Acta Radiologica Short Reports

JF - Acta Radiologica Short Reports

SN - 2047-9816

IS - 4

M1 - 20584601221094825

ER -

ID: 345019349